← back to search

P. James B. Dyck

Mayo Clinic · US
Area of research
Neurology · Physiology
Research interest
Research interests include Peripheral Neuropathies and Disorders, Pain Mechanisms and Treatments, Peripheral Nerve Disorders, and Botulinum Toxin and Related Neurological Disorders.
h-index
107
citations
45,327
works
755
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Insights Into CASPR1 and CASPR1/Contactin-1 Complex Autoimmune Nodopathies.
2026cited by 0position: contributordoi
Sensitivity of Nerve and Skin Biopsy and Fat Aspirate for Amyloid in Symptomatic Hereditary ATTR Amyloidosis With Peripheral Neuropathy.
2026cited by 0position: contributordoi
GLP-1RA-Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies: A Case-Control Evaluation.
2025cited by 6position: contributordoi
Clinical Manifestations and Treatment Responses in Pediatric Neurofascin 155-IgG4 Autoimmune Nodopathy.
2025cited by 4position: contributordoi
Natural History and Phenotypic Spectrum of Myofibrillar Myopathies and Myopathies Associated With MFM-Related Genes.
2025cited by 0position: contributordoi
Neurologic Clinical, Electrophysiologic, and Pathologic Characteristics of Primary vs Secondary Neurolymphomatosis.
2024cited by 5position: contributordoi
Clinicopathologic Findings in Patients With Paraneoplastic Neuropathies and Antibodies Strongly Associated With Cancer.
2024cited by 1position: contributordoi
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
JAMA 2023cited by 195position: middledoi
Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
2023cited by 6position: contributordoi
Clinical, Neurophysiologic, and Pathologic Features in Patients With Early-Onset Postradiation Neuropathy.
2023cited by 4position: contributordoi
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 108position: middledoi
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
2022cited by 79position: contributordoi
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Journal of Neurology 2022cited by 34position: middledoi
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
Neurology and Therapy 2022cited by 29position: middledoi
Comparison of immune checkpoint inhibitor-related neuropathies among patients with neuroendocrine and non-neuroendocrine tumours.
2022cited by 15position: contributordoi
Risk factors for lumbosacral radiculoplexus neuropathy.
2022cited by 9position: contributordoi
Variable differences of nerve conduction amplitudes versus velocities and distal latencies of healthy subjects assessed in ethnic cohorts.
2022cited by 2position: contributordoi
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Neurology and Therapy 2021cited by 56position: middledoi
Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
2021cited by 47position: contributordoi
Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
2021cited by 38position: contributordoi
Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability.
2021cited by 36position: contributordoi
Neuromuscular amyloidosis: Unmasking the master of disguise.
2021cited by 25position: contributordoi
Lumbosacral Radiculoplexus Neuropathy: Neurologic Outcomes and Survival in a Population-Based Study.
2021cited by 19position: contributordoi
Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus.
2021cited by 15position: contributordoi
Pure Motor Onset and IgM-Gammopathy Occurrence in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy.
2021cited by 8position: contributordoi
Novel imaging techniques using <sup>18</sup> F-florbetapir PET/MRI can guide fascicular nerve biopsy in amyloid multiple mononeuropathy.
2021cited by 3position: contributordoi
Acute immune sensory polyradiculopathy: a new variant of Guillain-Barré syndrome.
2021cited by 2position: contributordoi
Focal sensory chronic inflammatory demyelinating polyneuropathy (CIDP).
2021cited by 2position: contributordoi
Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial
European Journal of Neurology 2020cited by 71position: middledoi
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis.
2020cited by 16position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 25 papers (2020–2026)Divyanshu Dubey · Mayo Clinic in Arizona12 papers (2021–2026)John L. Berk · Boston University9 papers (2012–2022)Christopher J. Klein · Mayo Clinic in Arizona7 papers (2021–2026)Morie A. Gertz · Mayo Clinic6 papers (2015–2022)Laura Obici · University of Pavia6 papers (2012–2022)Michelle Mauermann · Jisc6 papers (2024–2026)Marcus V. Pinto · Mayo Clinic6 papers (2021–2026)Márcia Waddington‐Cruz · Universidade Federal do Rio de Janeiro5 papers (2015–2022)Giampaolo Merlini · Amyloidosis Foundation5 papers (2012–2022)Teresa Coelho · ERN GUARD-Heart5 papers (2018–2022)Shahar Shelly · Rambam Health Care Campus5 papers (2021–2022)Michael Polydefkis · Mayo Clinic in Arizona4 papers (2018–2022)Merrill D. Benson · The University of Texas Southwestern Medical Center4 papers (2015–2022)Shiangtung W. Jung · Ionis Pharmaceuticals (United States)4 papers (2018–2022)Nathan P. Staff · Neurology, Inc4 papers (2021–2026)Kamal Shouman · Mayo Clinic in Arizona4 papers (2021–2026)Sarah E. Berini · Mayo Clinic in Arizona4 papers (2024–2026)Peter D. Gorevic · Stony Brook Medicine3 papers (2012–2022)William J. Litchy · Mayo Clinic3 papers (2013–2021)